These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9496356)

  • 1. Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary.
    Wang PH; Chao HT; Lee WL
    Fertil Steril; 1998 Feb; 69(2):353-5. PubMed ID: 9496356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing a patient with presumed testosterone-secreting ovarian tumor.
    Lee WL; Wang PH; Tseng HS; Lin HD; Yuan CC; Chao HT
    Gynecol Oncol; 1999 Oct; 75(1):175-7. PubMed ID: 10502449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
    Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
    Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
    Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
    Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy.
    Gulley JL; Figg WD; Steinberg SM; Carter J; Sartor O; Higano CS; Petrylak DP; Chatta G; Hussain MH; Dahut WL
    J Urol; 2005 May; 173(5):1567-71. PubMed ID: 15821487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.
    McCluggage WG; Jamieson T; Dobbs SP; Grey A
    Gynecol Oncol; 2006 Mar; 100(3):623-5. PubMed ID: 16246403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian function suppression with a GnRH analogue: D-ser(But[t])[6]-Arzgly[10]-LHRH (Goserelin) in hormone dependent canine mammary cancer.
    Lombardi P; Florio S; Pagnini U; Crispino A; Avallone L
    J Vet Pharmacol Ther; 1999 Feb; 22(1):56-61. PubMed ID: 10211718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
    Nikolov A; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma.
    Shahinian VB; Kuo YF; Freeman JL; Orihuela E; Goodwin JS
    Cancer; 2005 Apr; 103(8):1615-24. PubMed ID: 15742331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH analogues as an adjuvant therapy for ovarian cancer patients.
    Rzepka-Górska I; Chudecka-Glaz A; Kosmider M; Malecha J
    Int J Gynaecol Obstet; 2003 May; 81(2):199-205. PubMed ID: 12706278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major hemorrhage in a patient with multiple submucous leiomyomata during the treatment of long-acting gonadotropin-releasing hormone agonist.
    Wang KC; Lee WL; Yuan CC; Wang PH
    Kaohsiung J Med Sci; 2000 Feb; 16(2):103-7. PubMed ID: 10816995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation.
    Wang PH; Chao HT; Liu RS; Cho YH; Ng HT; Yuan CC
    Gynecol Oncol; 2001 Dec; 83(3):596-8. PubMed ID: 11733978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up.
    Pierce SJ; Gazvani MR; Farquharson RG
    Fertil Steril; 2000 Nov; 74(5):964-8. PubMed ID: 11056241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.